• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

神经内分泌肿瘤的病理诊断:常见问题及初步解答。

The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.

机构信息

Divisions of Pathology, University of Turin at San Luigi Hospital, Orbassano, Torino, Italy.

出版信息

Virchows Arch. 2011 Apr;458(4):393-402. doi: 10.1007/s00428-011-1060-7. Epub 2011 Feb 23.

DOI:10.1007/s00428-011-1060-7
PMID:21344263
Abstract

Neuroendocrine neoplasms (NEN) develop in many organs, and although they share some pathological and clinical features, significant differences do exist among different tumor types and locations. The correct classification of NENs is based on the recently published WHO classification according to the various locations, and is relevant for the appropriate treatment in each group. The apparently easy diagnostic categorization in well-differentiated NENs, called neuroendocrine tumors, and poorly differentiated NENs, called neuroendocrine carcinomas, is complicated by the existence, among others, of different terminologies, morphological criteria of malignancy, combined exocrine-endocrine tumors, as well as of heterogeneous diagnostic, prognostic, and predictive markers. The present paper is an overview of the most frequently asked questions and an attempt to provide practical answers related to NEN diagnosis in the daily pathology work.

摘要

神经内分泌肿瘤(NEN)可发生于多个器官,虽然它们具有一些共同的病理和临床特征,但不同肿瘤类型和部位之间仍存在显著差异。NEN 的正确分类基于最近发布的 WHO 分类,根据不同部位进行分类,这对于每组患者的适当治疗非常重要。在分化良好的 NEN(称为神经内分泌肿瘤)和分化差的 NEN(称为神经内分泌癌)中,诊断分类似乎很简单,但由于存在其他因素,例如不同的术语、恶性的形态学标准、外分泌-内分泌混合肿瘤以及异质的诊断、预后和预测标志物,使诊断变得复杂。本文概述了最常被问到的问题,并尝试提供与日常病理工作中 NEN 诊断相关的实用答案。

相似文献

1
The pathological diagnosis of neuroendocrine tumors: common questions and tentative answers.神经内分泌肿瘤的病理诊断:常见问题及初步解答。
Virchows Arch. 2011 Apr;458(4):393-402. doi: 10.1007/s00428-011-1060-7. Epub 2011 Feb 23.
2
Lung and digestive neuroendocrine neoplasms. From WHO classification to biomarker screening: Which perspectives?肺和消化系统神经内分泌肿瘤。从世卫组织分类到生物标志物筛选:有哪些观点?
Ann Endocrinol (Paris). 2019 Jun;80(3):163-165. doi: 10.1016/j.ando.2019.04.011. Epub 2019 Apr 11.
3
[Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].[胃神经内分泌肿瘤亚型分类的共识与争议]
Zhonghua Wei Chang Wai Ke Za Zhi. 2017 Sep 25;20(9):977-981.
4
Aspects regarding nomenclature, classification and pathology of neuroendocrine neoplasms of the digestive system - a review.消化系统神经内分泌肿瘤的命名、分类及病理学相关方面——综述
Rom J Morphol Embryol. 2018;59(3):673-678.
5
Diagnostic and prognostic implications of the World Health Organization classification of neuroendocrine tumors.世界卫生组织神经内分泌肿瘤分类的诊断和预后意义
J Endocrinol Invest. 2008 Mar;31(3):216-23. doi: 10.1007/BF03345593.
6
[Clinical significance of new classification of gastroenteropancreatic neuroendocrine neoplasms].[胃肠胰神经内分泌肿瘤新分类的临床意义]
Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Jan;16(1):12-4.
7
Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).神经内分泌肿瘤异质性给 2010 年世界卫生组织分类带来不确定性:来自西班牙肿瘤登记处(R-GETNE)的真实世界数据。
Oncologist. 2018 Apr;23(4):422-432. doi: 10.1634/theoncologist.2017-0364. Epub 2018 Jan 12.
8
Neuroendocrine neoplasms of the gastroenteropancreatic system: pathology and classification.消化系统神经内分泌肿瘤:病理学和分类。
Horm Metab Res. 2011 Nov;43(12):825-31. doi: 10.1055/s-0031-1291307. Epub 2011 Nov 21.
9
Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.长链非编码 RNA 在肺神经内分泌肿瘤中的作用。
Endocr Pathol. 2020 Sep;31(3):254-263. doi: 10.1007/s12022-020-09626-1.
10
Classification and Prognostic Stratification of Bronchopulmonary Neuroendocrine Neoplasms.支气管肺神经内分泌肿瘤的分类和预后分层。
Neuroendocrinology. 2020;110(5):393-403. doi: 10.1159/000502776. Epub 2019 Aug 19.

引用本文的文献

1
Application of Metabolic Reprogramming to Cancer Imaging and Diagnosis.代谢重编程在癌症成像和诊断中的应用。
Int J Mol Sci. 2022 Dec 13;23(24):15831. doi: 10.3390/ijms232415831.
2
What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?2017 年世界卫生组织分类和第 8 版美国癌症联合委员会胰腺神经内分泌肿瘤分期系统有哪些新内容?
Korean J Radiol. 2019 Jan;20(1):5-17. doi: 10.3348/kjr.2018.0040. Epub 2018 Dec 27.
3
Mixed adenoneuroendocrine carcinoma in the stomach: a case report with a literature review.

本文引用的文献

1
Mammalian target of rapamycin signaling activation patterns in neuroendocrine tumors of the lung.肺神经内分泌肿瘤中雷帕霉素靶蛋白信号转导的激活模式。
Endocr Relat Cancer. 2010 Oct 29;17(4):977-87. doi: 10.1677/ERC-10-0157. Print 2010 Dec.
2
The pathologic classification of neuroendocrine tumors: a review of nomenclature, grading, and staging systems.神经内分泌肿瘤的病理学分类:命名法、分级和分期系统综述。
Pancreas. 2010 Aug;39(6):707-12. doi: 10.1097/MPA.0b013e3181ec124e.
3
Molecular markers associated with response to chemotherapy in gastro-entero-pancreatic neuroendocrine tumors.
胃混合性腺神经内分泌癌:一例报告并文献复习
Ann Surg Treat Res. 2018 May;94(5):270-273. doi: 10.4174/astr.2018.94.5.270. Epub 2018 Apr 30.
4
Histologically Proven Bronchial Neuroendocrine Tumors in MEN1: A GTE 51-Case Cohort Study.MEN1中经组织学证实的支气管神经内分泌肿瘤:一项51例病例队列研究
World J Surg. 2018 Jan;42(1):143-152. doi: 10.1007/s00268-017-4135-z.
5
Vascular endothelial growth factor (VEGF) pathway and neuroendocrine neoplasms (NENs): prognostic and therapeutic considerations.血管内皮生长因子(VEGF)通路与神经内分泌肿瘤(NENs):预后及治疗相关考量
Tumour Biol. 2014 Nov;35(11):10615-25. doi: 10.1007/s13277-014-2612-7. Epub 2014 Sep 18.
6
Bevacizumab-based combination therapy for advanced gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs): a systematic review of the literature.基于贝伐单抗的晚期胃肠胰神经内分泌肿瘤(GEP-NENs)联合治疗:文献系统评价
J Cancer Res Clin Oncol. 2015 Feb;141(2):295-305. doi: 10.1007/s00432-014-1757-5. Epub 2014 Jul 3.
7
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the XELBEVOCT study.贝伐单抗联合奥曲肽和小剂量节拍性卡培他滨治疗转移性中高分化神经内分泌肿瘤患者:XELBEVOCT研究
BMC Cancer. 2014 Mar 14;14:184. doi: 10.1186/1471-2407-14-184.
8
Proposal for a standardized pathology report of gastroenteropancreatic neuroendocrine tumors: prognostic significance of pathological parameters.胃肠胰神经内分泌肿瘤标准化病理报告的建议:病理参数的预后意义
Korean J Pathol. 2013 Jun;47(3):227-37. doi: 10.4132/KoreanJPathol.2013.47.3.227. Epub 2013 Jun 25.
与胃肠胰神经内分泌肿瘤化疗反应相关的分子标志物。
Endocr Relat Cancer. 2010 Sep 23;17(4):847-56. doi: 10.1677/ERC-09-0204. Print 2010 Dec.
4
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.神经内分泌胃肠胰腺肿瘤:ESMO诊断、治疗及随访临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v223-7. doi: 10.1093/annonc/mdq192.
5
Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.肺低级别和中级别神经内分泌癌(典型和不典型类癌肿瘤)的组织学特征。
Lung Cancer. 2011 Jan;71(1):34-41. doi: 10.1016/j.lungcan.2010.04.007. Epub 2010 May 11.
6
The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement.胃肠道和胰腺神经内分泌肿瘤的ENETS及AJCC/UICC TNM分类:一项声明
Virchows Arch. 2010 Jun;456(6):595-7. doi: 10.1007/s00428-010-0924-6. Epub 2010 Apr 27.
7
PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carcinoid tumors.PAX8 在分化良好的胰腺内分泌肿瘤中的表达:与临床病理特征的相关性,并与胃肠道和肺类癌肿瘤进行比较。
Am J Surg Pathol. 2010 May;34(5):723-9. doi: 10.1097/PAS.0b013e3181da0a20.
8
Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.乳腺癌中的神经内分泌分化:已确立的事实和未解决的问题。
Semin Diagn Pathol. 2010 Feb;27(1):69-76. doi: 10.1053/j.semdp.2009.12.003.
9
Pancreatic endocrine tumors: improved TNM staging and histopathological grading permit a clinically efficient prognostic stratification of patients.胰腺内分泌肿瘤:改良的 TNM 分期和组织病理学分级可对患者进行临床有效的预后分层。
Mod Pathol. 2010 Jun;23(6):824-33. doi: 10.1038/modpathol.2010.58. Epub 2010 Mar 19.
10
Pathology reporting of neuroendocrine tumors: application of the Delphic consensus process to the development of a minimum pathology data set.神经内分泌肿瘤的病理学报告:德尔菲共识过程在最小病理数据集开发中的应用。
Am J Surg Pathol. 2010 Mar;34(3):300-13. doi: 10.1097/PAS.0b013e3181ce1447.